Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy

Clinical trial NCT04058366 · COMPLETED

Trial details

NCT number: NCT04058366
Sponsor: Vertex Pharmaceuticals Incorporated
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cystic Fibrosis

Start date: 2019-12-05
Primary completion: 2022-12-16
Enrollment: 251

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.